Erste Asset Management Gmb H Viking Therapeutics, Inc. Transaction History
Erste Asset Management Gmb H
- $8.35 Trillion
- Q3 2024
A detailed history of Erste Asset Management Gmb H transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 47,000 shares of VKTX stock, worth $2.59 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
47,000Holding current value
$2.59 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
66.2MCall Options Held
5.32MPut Options Held
3.03M-
Vanguard Group Inc Valley Forge, PA10.2MShares$560 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$332 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$257 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$117 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$103 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.22B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...